MedTrace Logo

Effects of Proton Pump Inhibitors on Kidney Transplant Recipients

NCT03123796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-12-27

No results posted yet for this study

Summary

Use of proton pump inhibitors (PPIs) is quite common among renal transplant recipients and reduced kidney functions and hypomagnesemia with the use of PPIs have been reported. In this study, investigation of the effects of PPI use on the outcome of kidney transplant recipients is aimed.

Conditions

  • Transplant Dysfunction
  • Magnesium Disorder

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Yasar Caliskan, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-09-30
Completion
2017-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03123796 on ClinicalTrials.gov